| Glutamatergic neurometabolite levels in major depressive disorder: a systematic review and meta-analysis of proton magnetic resonance spectroscopy studies S Moriguchi, A Takamiya, Y Noda, N Horita, M Wada, S Tsugawa, ... Molecular psychiatry 24 (7), 952-964, 2019 | 282 | 2019 |
| Kynurenine pathway in depression: A systematic review and meta-analysis K Ogyu, K Kubo, Y Noda, Y Iwata, S Tsugawa, Y Omura, M Wada, ... Neuroscience & Biobehavioral Reviews 90, 16-25, 2018 | 262 | 2018 |
| Kynurenic acid in schizophrenia: a systematic review and meta-analysis E Plitman, Y Iwata, F Caravaggio, S Nakajima, JK Chung, P Gerretsen, ... Schizophrenia bulletin 43 (4), 764-777, 2017 | 228 | 2017 |
| Glutamate-mediated excitotoxicity in schizophrenia: a review E Plitman, S Nakajima, C de la Fuente-Sandoval, P Gerretsen, ... European Neuropsychopharmacology 24 (10), 1591-1605, 2014 | 184 | 2014 |
| Glutamatergic neurometabolite levels in patients with ultra-treatment-resistant schizophrenia: a cross-sectional 3T proton magnetic resonance spectroscopy study Y Iwata, S Nakajima, E Plitman, F Caravaggio, J Kim, P Shah, W Mar, ... Biological psychiatry 85 (7), 596-605, 2019 | 121 | 2019 |
| Effects of glutamate positive modulators on cognitive deficits in schizophrenia: a systematic review and meta-analysis of double-blind randomized controlled trials Y Iwata, S Nakajima, T Suzuki, RSE Keefe, E Plitman, JK Chung, ... Molecular psychiatry 20 (10), 1151-1160, 2015 | 112 | 2015 |
| Elevated myo-inositol, choline, and glutamate levels in the associative striatum of antipsychotic-naive patients with first-episode psychosis: a proton magnetic resonance … E Plitman, C de la Fuente-Sandoval, F Reyes-Madrigal, S Chavez, ... Schizophrenia bulletin 42 (2), 415-424, 2016 | 110 | 2016 |
| Neuroimaging findings in treatment-resistant schizophrenia: a systematic review: lack of neuroimaging correlates of treatment-resistant schizophrenia S Nakajima, H Takeuchi, E Plitman, G Fervaha, P Gerretsen, ... Schizophrenia research 164 (1-3), 164-175, 2015 | 107 | 2015 |
| Psychosis in frontotemporal dementia S Shinagawa, S Nakajima, E Plitman, A Graff-Guerrero, M Mimura, ... Journal of Alzheimer's disease 42 (2), 485-499, 2014 | 100 | 2014 |
| Glutamatergic and GABAergic metabolite levels in schizophrenia-spectrum disorders: a meta-analysis of 1H-magnetic resonance spectroscopy studies T Nakahara, S Tsugawa, Y Noda, F Ueno, S Honda, M Kinjo, H Segawa, ... Molecular psychiatry 27 (1), 744-757, 2022 | 99 | 2022 |
| The effects of aging on insight into illness in schizophrenia: a review P Gerretsen, E Plitman, TK Rajji, A Graff‐Guerrero International journal of geriatric psychiatry 29 (11), 1145-1161, 2014 | 90 | 2014 |
| Association of age, antipsychotic medication, and symptom severity in schizophrenia with proton magnetic resonance spectroscopy brain glutamate level: a mega-analysis of … K Merritt, PK McGuire, A Egerton, A Aleman, W Block, OJN Bloemen, ... JAMA psychiatry 78 (6), 667-681, 2021 | 88 | 2021 |
| The impact of delay in clozapine initiation on treatment outcomes in patients with treatment-resistant schizophrenia: a systematic review P Shah, Y Iwata, E Plitman, EE Brown, F Caravaggio, J Kim, S Nakajima, ... Psychiatry research 268, 114-122, 2018 | 87 | 2018 |
| Reduced Insulin Sensitivity Is Related to Less Endogenous Dopamine at D2/3 Receptors in the Ventral Striatum of Healthy Nonobese Humans F Caravaggio, C Borlido, M Hahn, Z Feng, G Fervaha, P Gerretsen, ... International Journal of Neuropsychopharmacology 18 (7), pyv014, 2015 | 83 | 2015 |
| Can we accurately classify schizophrenia patients from healthy controls using magnetic resonance imaging and machine learning? A multi-method and multi-dataset study JL Winterburn, AN Voineskos, GA Devenyi, E Plitman, ... Schizophrenia research 214, 3-10, 2019 | 82 | 2019 |
| The role of maternal immune activation in altering the neurodevelopmental trajectories of offspring: A translational review of neuroimaging studies with implications for autism … E Guma, E Plitman, MM Chakravarty Neuroscience & Biobehavioral Reviews 104, 141-157, 2019 | 79 | 2019 |
| Glutathione levels and activities of glutathione metabolism enzymes in patients with schizophrenia: A systematic review and meta-analysis S Tsugawa, Y Noda, R Tarumi, Y Mimura, K Yoshida, Y Iwata, M Elsalhy, ... Journal of Psychopharmacology 33 (10), 1199-1214, 2019 | 72 | 2019 |
| Lifetime history of depression predicts increased amyloid-β accumulation in patients with mild cognitive impairment JK Chung, E Plitman, S Nakajima, TW Chow, MM Chakravarty, ... Journal of Alzheimer's Disease 45 (3), 907-919, 2015 | 71 | 2015 |
| Acute and long-term effects of electroconvulsive therapy on human dentate gyrus A Takamiya, E Plitman, JK Chung, M Chakravarty, A Graff-Guerrero, ... Neuropsychopharmacology 44 (10), 1805-1811, 2019 | 67 | 2019 |
| Dopaminergic dysfunction and excitatory/inhibitory imbalance in treatment-resistant schizophrenia and novel neuromodulatory treatment M Wada, Y Noda, Y Iwata, S Tsugawa, K Yoshida, H Tani, Y Hirano, ... Molecular Psychiatry 27 (7), 2950-2967, 2022 | 64 | 2022 |
